S'abonner

Prenatal and postnatal bisphenol A exposure and asthma development among inner-city children - 27/02/13

Doi : 10.1016/j.jaci.2012.12.1573 
Kathleen M. Donohue, MD a, b, , Rachel L. Miller, MD a, b, c, e, Matthew S. Perzanowski, PhD b, c, Allan C. Just, PhD b, c, Lori A. Hoepner, MS b, c, Srikesh Arunajadai, PhD d, Stephen Canfield, MD, PhD a, David Resnick, MD e, Antonia M. Calafat, PhD f, Frederica P. Perera, DrPH b, c, Robin M. Whyatt, DrPH b, c
a Division of Pulmonary, Allergy and Critical Care, Columbia University School of Physicians and Surgeons, New York, NY 
e Division of Pediatric Allergy and Immunology, Columbia University School of Physicians and Surgeons, New York, NY 
b Columbia Center for Children’s Environmental Health, Mailman School of Public Health, Columbia University, New York, NY 
c Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 
d Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 
f Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, Ga 

Corresponding author: Kathleen M. Donohue, MD, Instructor of Clinical Medicine, Columbia University, Division of General Medicine, 622 West 168th St, PH9E Rm 105K, New York, NY 10032.

Abstract

Background

Bisphenol A (BPA) is used widely to manufacture food container linings. Mouse models suggest exposure to BPA might increase allergic inflammation.

Objectives

We hypothesized that BPA exposure, as assessed based on urinary BPA concentrations, would be associated with increased odds of wheeze and asthma and increased fraction of exhaled nitric oxide (Feno) values in children.

Methods

The Columbia Center for Children’s Environmental Health recruited pregnant women for a prospective birth cohort study (n = 568). Mothers during the third trimester and children at ages 3, 5, and 7 years provided spot urine samples. Total urinary BPA concentrations were measured by using online solid-phase extraction, high-performance liquid chromatography, isotope-dilution tandem mass spectrometry. Wheeze in the last 12 months was measured by using questionnaires at ages 5, 6, and 7 years. Asthma was determined by a physician once between ages 5 and 12 years. Feno values were measured at ages 7 to 11 years.

Results

Prenatal urinary BPA concentrations were associated inversely with wheeze at age 5 years (odds ratio [OR], 0.7; 95% CI, 0.5-0.9; P = .02). Urinary BPA concentrations at age 3 years were associated positively with wheeze at ages 5 years (OR, 1.4; 95% CI, 1.1-1.8; P = .02) and 6 years (OR, 1.4; 95% CI, 1.0-1.9; P = .03). BPA concentrations at age 7 years were associated with wheeze at age 7 years (OR, 1.4; 95% CI, 1.0-1.9; P = .04) and Feno values (β = 0.1; 95% CI, 0.02-0.2; P = .02). BPA concentrations at ages 3, 5, and 7 years were associated with asthma (OR, 1.5 [95% CI, 1.1-2.0], P = .005; OR, 1.4 [95% CI, 1.0-1.9], P = .03; and OR, 1.5 [95% CI, 1.0-2.1], P = .04, respectively).

Conclusions

This is the first report of an association between postnatal urinary BPA concentrations and asthma in children.

Le texte complet de cet article est disponible en PDF.

Key words : Bisphenol A, asthma, wheeze, children, exhaled nitric oxide, IgE, cohort study

Abbreviations used : BPA, Feno, OR, QC


Plan


 Supported by the National Institute of Environmental Health Sciences (RC2ES018784, R01ES014393, P30ES009089, R01ES08977, R01ES013163, and PO1ES09600), the US Environmental Protection Agency (R827027, RD832141, and RD834509), the John and Wendy Neu Family Foundation, the Blanchette Hooker Rockefeller Fund, New York Community Trust, the Educational Foundation of America, and the Millstream Fund. The findings expressed in this article are the opinions of the authors and do not necessarily reflect the official opinion of the Centers for Disease Control and Prevention.
 Disclosure of potential conflict of interest: K. M. Donohue has received research and travel support from the National Institutes of Health (NIH), is employed by Columbia University, and has received travel support from the Alpha-1 Foundation. R. L. Miller has received research support from the NIH and the US Environmental Protection Agency (EPA). M. S. Perzanowski has received research support from the NIH and has received travel support from Indoor Biotechnology. L. A. Hoepner has received research support from the National Institute of Environmental Health Sciences. S. Canfield has received research support from the NIH and EPA and has received travel support from the NIH. D. Resnick has received research support from the NIH. R. M. Whyatt has received research and travel support from the NIH and is employed by Columbia University. The rest of the authors declare that they have no relevant conflicts of interest.


© 2013  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 131 - N° 3

P. 736 - mars 2013 Retour au numéro
Article précédent Article précédent
  • Maternal smoking affects lung function and airway inflammation in young children with multiple-trigger wheeze
  • Satu Kalliola, Anna S. Pelkonen, L. Pekka Malmberg, Seppo Sarna, Mauri Hämäläinen, Ilkka Mononen, Mika J. Mäkelä
| Article suivant Article suivant
  • Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease
  • Maxie Kohler, AnnSofi Sandberg, Sanela Kjellqvist, Andreas Thomas, Reza Karimi, Sven Nyrén, Anders Eklund, Mario Thevis, C. Magnus Sköld, Åsa M. Wheelock

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.